Trial Profile

A Real World Observational Study to Evaluate the Impact of Adalimumab Therapy on Quality of Life and Psychological Factors Associated With Severe Psoriasis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 May 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adalimumab (Primary)
Indications Plaque psoriasis; Psoriasis
Focus Therapeutic Use
Acronyms Body Image
Sponsors Abbott Laboratories; AbbVie

Most Recent Events

01 May 2020 Results published in the Journal of Dermatological Treatment
02 Jun 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
19 Nov 2013 Planned number of patients changed from 150 to 152 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com